Nathalie Chabbert-Buffet
Chabbert-Buffet, Nathalie, 1963-...., endocrinologue
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Chabbert-Buffet, Nathalie 1963-...
Chabbert-Buffet, Nathalie
VIAF ID: 215053041 ( Personal )
Permalink: http://viaf.org/viaf/215053041
Preferred Forms
4xx's: Alternate Name Forms (3)
Works
| Title | Sources |
|---|---|
| Actualités en pathologie mammaire |
|
| Le cancer du sein : actualités, perspectives (évocation non exhaustive) |
|
| Le centre de suivi des femmes à risque de cancer du sein et de l'ovaire : raison d'être et organisation |
|
| Contraceptifs oestroprogestatifs : pilule, patch, anneau... |
|
| Densité mammaire : mécanismes biologiques et implications cliniques |
|
| Déterminants du recours au dépistage du cancer du col de l'utérus chez les femmes obèses |
|
| Determinants of cervical cancer uptake among obese women. |
|
| Development and conceptual validation of a questionnaire to help contraceptive choice: CHLOE |
|
| Effectiveness of a therapeutic multiple-lifestyle intervention taking into account the periconceptional environment in the management of infertile couples: study design of a randomized controlled trial - the PEPCI study |
|
| Effects of antiprogestins on the uterus |
|
| Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial. |
|
| Effets des modulateurs sélectifs du récepteur de la progestérone dans l'endomètre humain |
|
| ELEVATION DE LA PROGESTERONE EN PHASE FOLLICULAIRE : UN MARQUEUR DE LA FORME NON CLASSIQUE DE BLOC EN 21 HYDROXYLASE ET UNE CAUSE D'INFERTILITE (ENDOCRINOLOGIE ET METABOLISME) |
|
| [Epidemiological data for uterine fibroids in France in 2010-2012 in medical center--analysis from the French DRG-based information system (PMSI)]. |
|
| Etude de la dynamique des interactions fonctionnelles entre le récepteur de la progestérone et ses corégulateurs transcriptionnels |
|
| Evidence for associated cutaneous microangiopathy in diabetic patients with neuropathic foot ulceration |
|
| [Expert centre Cancer du sein et Grossesse (CALG): Concordance between the proposed therapeutics and those finally received] |
|
| Fertilité après don d'ovocytes en cas d'endométriose profonde |
|
| [Fertility and deep infiltrating endometriosis]. |
|
| [Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]. |
|
| [Fertility preservation in oncology: updates in 2015] |
|
| French multicentric survey of outcome of pregnancy in women with pregestational diabetes. |
|
| The future of women's contraception: stakes and modalities |
|
| Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review |
|
| The history and use of the progesterone receptor modulator ulipristal acetate for heavy menstrual bleeding with uterine fibroids |
|
| Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort--a factor analysis. |
|
| Hormones sexuelles et mortalité chez les hommes au cours du vieillissement dans l'étude de cohorte des Trois Cités |
|
| Impact des traitements médicaux du cancer sur la fertilité : prédiction de la fonction ovarienne après traitement |
|
| [Impact of osteopathic manipulative therapy in patient with deep with colorectal endometriosis: A classification based on symptoms and quality of life] |
|
| [Management of endometriosis: CNGOF-HAS practice guidelines (short version)] |
|
| [Medical treatment of endometriosis: Hormonal treatment of pain, impact on evolution and future perspectives]. |
|
| [Medical treatments of presumed benign ovarian tumors]. |
|
| [Modalities for the functionning of a Care Center for women at high risk for breast and ovarian cancers: The French experience of Tenon Hospital] |
|
| [Monitoring of postmenopausal women] |
|
| Multiple miscarriages are associated with the risk of ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition |
|
| [New medical treatments for painful endometriosis: CNGOF-HAS Endometriosis Guidelines] |
|
| A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer. |
|
| Outcomes of first IVF/ICSI in young women with diminished ovarian reserve. |
|
| [Part II drafted from the short text of the French guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Systemic and intraperitoneal treatment |
|
| Place des traitements médicaux : indication, durée, efficacité, chez la femme porteuse de fibromes utérins symptomatiques en période d’activité génitale |
|
| Pregnancy after breast cancer: a need for global patient care, starting before adjuvant therapy |
|
| [Pregnancy after cancer: for whom and when?] |
|
| Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis-associated infertility: GnRH-agonist versus GnRH-antagonist |
|
| Préservation de la fertilité dans les tumeurs ovariennes malignes : expérience du centre de prise en charge des tumeurs ovariennes labélisé European Society of Gynaecological Oncology (ESGO) et centre expert Cancer Associé à La Grossesse (CALG), à l'hôpital Tenon, APHP Sorbonne Université |
|
| Prévention de l'infertilité : pratiques des médecins généralistes, déterminants et perspectives de mise en oeuvre par la méthode du focus group |
|
| Prise en charge de l'obésité en 2012 : le point de vue de l'endocrinologue |
|
| Progesterone receptor isoforms implication in breast cancer metastasis : in vitro studies in MDA-MB 231 cells. |
|
| Prognosis of HER2-positive pregnancy-associated breast cancer: Analysis from the French CALG (Cancer Associé à La Grossesse) network |
|
| Proportion of Cytotoxic Peripheral Blood Natural Killer Cells and T-Cell Large Granular Lymphocytes in Recurrent Miscarriage and Repeated Implantation Failure: Case-Control Study and Meta-analysis |
|
| Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort. |
|
| Risks of endometrial cancer associated with different hormone replacement therapies in the E3N cohort, 1992-2008. |
|
| [Role of GnRH agonists in preserving female fertility]. |
|
| Scoring to predict the possibility of upgrades to malignancy in atypical ductal hyperplasia diagnosed by an 11-gauge vacuum-assisted biopsy device: an external validation study. |
|
| [Selective progesterone receptor modulators: future clinical applications]. |
|
| Sex Steroid Hormones and Mortality in Elderly Men from the ThreeCity Cohort Study. |
|
| Signalisation androgénique dans les cellules de Sertoli. |
|
| Soluble endoglin in preeclamptic patients with or without HELLP syndrome. |
|
| Steroid profiling in preeclamptic women: evidence for aromatase deficiency. |
|
| Stéroidogénèse anormale et statut anti-angiogénique au cours de la prééclampsie, utilisation potentielle comme biomarqueurs |
|
| Surpoids, obésité et survie après cancer du sein dans la cohorte E3N |
|
| Toward a new concept of "natural balance" in oral estroprogestin contraception |
|
| Tumeurs bénignes du sein : recommandations pour la pratique clinique du Collège national des gynécologues et obstétriciens français (CNGOF) – Texte court |
|
| Tumor necrosis factor (TNF)-α, soluble TNF receptors and endometrial cancer risk: the EPIC study. |
|
| Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial |
|
| Use of the EFI score in endometriosis-associated infertility: A cost-effectiveness study |
|
| Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic |
|
| Women's preferences for menstrual bleeding frequency: results of the Inconvenience Due to Women's Monthly Bleeding (ISY) survey. |
|
